A Pilot Study of KPL-914 in Recurrent Pericarditis
NCT03980522
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Recurrent Pericarditis
Interventions
DRUG:
KPL-914
Sponsor
Kiniksa Pharmaceuticals (UK), Ltd.